Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-thalassemia syndromes.

A Bank1, C Dobkin

  • 1Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032.

Birth Defects Original Article Series
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of DNA test for hip dysplasia failed in Danish Labrador Retrievers.

Animal genetics·2020
Same author

Molecular carrier testing for the fragile X syndrome: Issues for genetic counselors.

Journal of genetic counseling·2013
Same author

Transfer and expression of the human multiple drug resistance gene as potential human gene therapy.

Cytotechnology·2012
Same author

Excess alpha chain synthesis relative to beta chain synthesis in thalassaemia major and minor.

Nature·2010
Same author

Introduction.

Kronos (Bellville, South Africa)·2009
Same author

Anthropology and portrait photography: Gustav Fritsch's "Natives of South Africa," 1863-1872.

Kronos (Bellville, South Africa)·2009
Same journal

A case of short-rib syndrome without polydactyly in a stillborn: a new type?

Birth defects original article series·1996
Same journal

Hand malformations in the aborted embryo: an important source of genetic information.

Birth defects original article series·1996
Same journal

Colophon: on doing morphology.

Birth defects original article series·1996
Same journal

Congenital eye malformations: a descriptive epidemiologic study in about one million newborns in Italy.

Birth defects original article series·1996
Same journal

CHARGE association in a neonate exposed in utero to carbon monoxide.

Birth defects original article series·1996
Same journal

Fetal valproate embryopathy in twins: genetic modification of the response to a teratogen.

Birth defects original article series·1996
See all related articles

Beta-thalassemias result from defects in the beta-globin gene. Single nucleotide mutations are the most common cause, leading to altered gene expression and disease phenotypes.

Area of Science:

  • Genetics
  • Molecular Biology
  • Hematology

Background:

  • Beta-thalassemias encompass a group of inherited blood disorders characterized by reduced or absent synthesis of beta-globin chains.
  • Genetic defects in the beta-globin gene are the underlying cause of beta-thalassemias.

Purpose of the Study:

  • To elucidate the molecular mechanisms of beta-thalassemias caused by various mutations in the beta-globin gene.
  • To identify and characterize specific genetic alterations leading to different forms of beta-thalassemia.

Main Methods:

  • Analysis of beta-globin gene structure and sequence in affected individuals.
  • Identification of single nucleotide mutations, deletions, and splice site alterations.
  • Investigation of mRNA splicing patterns and their correlation with disease severity.

Related Experiment Videos

Main Results:

  • Over 30 distinct single nucleotide mutations identified as common causes of beta-thalassemia.
  • Mutations in promoter regions, coding sequences, and splice junctions lead to beta(+) and beta(0) thalassemia.
  • Deletions at the 3' end of the beta-globin gene observed in some Indian patients.
  • Novel splice sites generated by mutations result in abnormal mRNA splicing and thalassemia phenotypes.

Conclusions:

  • Single nucleotide mutations are the predominant cause of beta-thalassemias, affecting gene expression through various mechanisms.
  • Mutations impacting splicing efficiency and accuracy are critical determinants of beta-thalassemia severity.
  • Understanding these genetic defects is crucial for accurate diagnosis and potential therapeutic strategies.